LobbyingBlood Cancer United lobbying by quarter
Blood Cancer United's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q3 2024; the issues it reports most are Medicare/Medicaid.
Blood Cancer United
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $40K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$100K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Crossroads Strategies | $100K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Crossroads Strategies | $40K |
| 06/03for Q2 | Crossroads Strategies | Under $5,000 |
| 25/10/16for Q2 2025 | Crossroads Strategies | Under $5,000 |
| 25/07/20for Q2 2025 | Crossroads Strategies | Under $5,000 |
| 25/04/20for Q1 2025 | Crossroads Strategies | Under $5,000 |
| 25/01/19for Q4 2024 | Crossroads Strategies | $30K |
| 24/10/20for Q3 2024 | Crossroads Strategies | $30K |
| 24/08/13for Q3 2024 | Crossroads Strategies | Under $5,000 |